SOX2 expression and amplification in gliomas and glioma cell lines.
about
Yin Yang 1 is associated with cancer stem cell transcription factors (SOX2, OCT4, BMI1) and clinical implicationPluripotency Genes and Their Functions in the Normal and Aberrant Breast and BrainRole of SOX family of transcription factors in central nervous system tumorsAutologous transplantation of intestine-isolated glia cells improves neuropathology and restores cognitive deficits in β amyloid-induced neurodegenerationTargeting SOX2 as a Therapeutic Strategy in GlioblastomaYB-1 regulates Sox2 to coordinately sustain stemness and tumorigenic properties in a phenotypically distinct subset of breast cancer cellsMolecular culprits generating brain tumor stem cellsSox2 promotes malignancy in glioblastoma by regulating plasticity and astrocytic differentiationActivation of SOX2 expression by BRD4-NUT oncogenic fusion drives neoplastic transformation in NUT midline carcinoma.EphA2 promotes infiltrative invasion of glioma stem cells in vivo through cross-talk with Akt and regulates stem cell properties.Genetic and epigenetic modifications of Sox2 contribute to the invasive phenotype of malignant gliomasGlioblastoma development in mouse brain: general reduction of OCTs and mislocalization of OCT3 transporter and subsequent uptake of ASP(+) substrate to the nucleiElevating SOX2 levels deleteriously affects the growth of medulloblastoma and glioblastoma cells.Important miRs of pathways in different tumor types.Sox2 suppresses the invasiveness of breast cancer cells via a mechanism that is dependent on Twist1 and the status of Sox2 transcription activity.Deregulated proliferation and differentiation in brain tumors.Profiling gene promoter occupancy of Sox2 in two phenotypically distinct breast cancer cell subsets using chromatin immunoprecipitation and genome-wide promoter microarraysAntigenic and Genotypic Similarity between Primary Glioblastomas and Their Derived Neurospheres.Malignant clinical features of anaplastic gliomas without IDH mutation.Development of a Sox2 reporter system modeling cellular heterogeneity in glioma.Associations between SOX2 and miR-200b expression with the clinicopathological characteristics and prognosis of patients with glioma.Cellular-based immunotherapies for patients with glioblastoma multiforme.Comparative transcriptomics reveals similarities and differences between astrocytoma grades.Studying a complex tumor: potential and pitfalls.Sex-determining region Y-box 2 expression predicts poor prognosis in human ovarian carcinoma.Cathepsin B and uPAR regulate self-renewal of glioma-initiating cells through GLI-regulated Sox2 and Bmi1 expressionTransmembrane protein CD9 is glioblastoma biomarker, relevant for maintenance of glioblastoma stem cells.Oxidative stress induces the acquisition of cancer stem-like phenotype in breast cancer detectable by using a Sox2 regulatory region-2 (SRR2) reporterNon-invasive neural stem cells become invasive in vitro by combined FGF2 and BMP4 signalingCancer Stem Cells in Glioblastoma Multiforme.ER stress inducer tunicamycin suppresses the self-renewal of glioma-initiating cell partly through inhibiting Sox2 translation.Dendrosomal curcumin nanoformulation downregulates pluripotency genes via miR-145 activation in U87MG glioblastoma cells.SOX2 and cancer: current research and its implications in the clinicThe dark side of SOX2: cancer - a comprehensive overview.mTOR inhibition decreases SOX2-SOX9 mediated glioma stem cell activity and temozolomide resistance.Transcriptional profiling of dividing tumor cells detects intratumor heterogeneity linked to cell proliferation in a brain tumor model.Sox2: regulation of expression and contribution to brain tumors.Metformin treatment reduces temozolomide resistance of glioblastoma cells.A BMP7 variant inhibits the tumorigenic potential of glioblastoma stem-like cells.Stem cell niches in glioblastoma: a neuropathological view
P2860
Q26745972-29E6D646-5C92-4767-99C5-9847B78BF52DQ26851968-3BDE65D3-FA25-4E19-9550-C4A84AF1C958Q26860974-8DD5AD78-6DBF-433A-8714-2178EE0C03DEQ27334336-7F799E23-C33F-49A3-B0CC-C4C0E6E10AEBQ28079501-723E36D3-CB15-43D9-BDC3-49F3D0F473D4Q33628528-53FE26F8-5639-4508-ABBF-0591C86C22CAQ33635399-3864300F-925A-4FA3-93D2-82C4CB361299Q33891224-283ACA36-7104-4A0C-B90B-97B05B9737E3Q33901136-796E8C75-46B7-4B77-A712-9A5A1412F3B6Q33993779-6E7A0CD7-CE54-4195-AD3C-156337B8F322Q34070508-69FCBB63-50C0-444F-BA2C-E662388D2A8DQ34083251-D5C0FD85-5870-40C8-B1C9-F123A8C72A62Q34399678-A0B3AB52-2626-40D4-9BEA-A81EEB4236D9Q34566039-69826286-3DF6-424E-8CC5-42EC58D797BAQ34788271-65277F56-178B-404C-8922-C172E2395106Q34859989-97D999FF-0DFF-4CCC-A1A8-3367DB08FF37Q35000680-303A741F-117E-41A7-840A-6DE3D7E7428AQ35173279-9FC4FD26-E504-4BCE-8792-CECC24AA3B09Q35788726-00BD2BCD-6EE9-4A1A-B20B-62C57E1A49C9Q35788935-938F8264-578F-458D-8036-EE557513DA24Q35802967-9D0507F4-E7F1-46DC-BF2C-DA487BFC4F45Q35821404-42F91EE8-6DFD-49A7-B1DC-5BEB1825EB8AQ35870174-74081609-D32B-4289-8145-897D84019675Q35929525-45D2219C-EE04-4DD3-A9F0-E7E02E59A151Q36028245-81816470-F87C-4A6A-9984-3474B4934998Q36636347-8EF9F1CF-EDD4-4FA4-B22D-98E873523131Q36729480-2D95103D-D6C5-4A8C-8C58-7E782C5FBAAFQ36772053-4B95C576-46C1-4C5C-8EC3-DA51112C3B3CQ37096486-6A6CA375-0BE5-4ACE-A4D2-B98E7E85A680Q37210629-21113003-A3B6-4F41-BBBB-481DAF29B040Q37392723-59432B46-2242-4D0A-A87E-EBE635407588Q37490603-4D26F2BD-AEDD-496E-B7BB-6C13BCBE33F3Q38239137-01595CBE-8C90-4C45-854A-FE946844D785Q38733504-BC91716D-6903-41A3-8758-1764C1C42108Q38794065-59AF547B-F86B-4C68-9F1C-BCB39B20F582Q38833930-ACD9CE57-BE7F-4205-AD07-1DE6E7739095Q38845654-B6CF315F-BFEF-4BFA-B8E1-D0B00D1E3024Q39239705-F0601D25-11D7-4307-AC40-809009A140C7Q39357751-A63CB638-B507-4780-A018-09C08DBF68DCQ41451541-E76031B5-38AF-4D55-8E24-207C488D234E
P2860
SOX2 expression and amplification in gliomas and glioma cell lines.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
SOX2 expression and amplification in gliomas and glioma cell lines.
@en
SOX2 expression and amplification in gliomas and glioma cell lines.
@nl
type
label
SOX2 expression and amplification in gliomas and glioma cell lines.
@en
SOX2 expression and amplification in gliomas and glioma cell lines.
@nl
prefLabel
SOX2 expression and amplification in gliomas and glioma cell lines.
@en
SOX2 expression and amplification in gliomas and glioma cell lines.
@nl
P2093
P1476
SOX2 expression and amplification in gliomas and glioma cell lines.
@en
P2093
Davide Schiffer
Guido Valente
Laura Annovazzi
Marta Mellai
Valentina Caldera
P304
P577
2011-05-01T00:00:00Z